Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
9
GPCR Quote, Financials, Valuation and Earnings
Last price:
$19.55
Seasonality move
:
32.88%
Day range:
$18.94 - $19.74
52-week range:
$13.22 - $45.37
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.37x
Volume:
544.9K
Avg. volume:
766K
1-year change:
-56.11%
Market cap:
$1.1B
Revenue:
--
EPS (TTM):
-$2.59
Earnings Data
Next earnings date for GPCR
Aug 08
2025
Most recent earnings per share
-$0.81
Missed by $0.58
(May 8/2025)
Consensus Estimate
-$0.23
(May 8/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
GPCR Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | -- | -- | -- | -$0.39 | -- |
| 08/08/2025 | Q2 | -- | -- | -- | -$0.36 | -- |
| 05/08/2025 | Q1 | -- | -- | -$0.81 | -$0.23 | -$0.58 |
| 02/27/2025 | Q4 | -- | -- | -$0.64 | -$0.17 | -$0.47 |
| 11/13/2024 | Q3 | -- | -- | -$0.60 | -$0.19 | -$0.41 |
| 08/08/2024 | Q2 | -- | -- | -$0.54 | -$0.23 | -$0.32 |
| 05/09/2024 | Q1 | -- | -- | -$0.57 | -$0.22 | -$0.35 |
| 03/08/2024 | Q4 | -- | -- | -$0.48 | -$0.21 | -$0.27 |
| 11/17/2023 | Q3 | -- | -- | -$0.63 | -$0.22 | -$0.41 |
| 08/10/2023 | Q2 | -- | -- | -$0.60 | -$0.27 | -$0.33 |
| 05/11/2023 | Q1 | -- | -- | -$0.75 | -- | -- |
| 12/31/2022 | Q4 | -- | -- | -$0.31 | -- | -- |
| 09/30/2022 | Q3 | -- | -- | -$0.49 | -- | -- |
| 06/30/2022 | Q2 | -- | -- | -$0.61 | -- | -- |
| 03/31/2022 | Q1 | -- | -- | -$0.51 | -- | -- |
| 12/31/2021 | Q4 | -- | -- | -$0.61 | -- | -- |
Structure Therapeutics Earnings Questions
-
How Much did Structure Therapeutics Generate in Revenue Last Quarter?
Structure Therapeutics reported -- worth of top line sales in its most recent quarter.
-
Did Structure Therapeutics Beat Earnings Last Quarter?
Structure Therapeutics announced earnings per share of -$0.81 which represents a miss of analyst forecast a -$0.23 per share.
-
Is Structure Therapeutics Profitable?
Structure Therapeutics reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Structure Therapeutics EPS Next Year?
Structure Therapeutics's earnings are forecast to decrease from -$2.34 per share to -$0.76 per share next year representing a decrease of -53.6%.
-
When is Structure Therapeutics's Earnings Date?
Structure Therapeutics's next earnings date is August 8, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
